NeoGenomics (NEO)

NeoGenomics (NEO) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• NEO last traded at $16.77, -3.51% on the day.
• NeoGenomics: market cap $2.25B, P/E -68.0, revenue $787.75M over the last four quarters.
• Over the past year NEO returned 73.07%; year to date 42.60%.

Updated 2026-11-02 17:58 UTC